Lv1
70 积分 2025-06-28 加入
Isolation and characterization of charge variants of infliximab biosimilar HS626
5个月前
已完结
Development of a Manufacturing Process for a Key (S)-5-(2,2-Dimethyltetrahydro-2H-pyran-4-yl)-1H-indole Intermediate for Orforglipron. Part II. Development of a CSTR Process for Evans Auxiliary-Assisted Asymmetric 1,4-Addition
6个月前
已完结
皖公网安备34019202002308
